Influencing factors and current status of heart failure in patients with unstable angina pectoris
10.3969/j.issn.1006-2483.2025.06.041
- VernacularTitle:不稳定型心绞痛患者心力衰竭发生现状及其影响因素分析
- Author:
Nan FENG
1
;
Xing WU
1
;
Qingrong ZHOU
1
;
Jianfeng WANG
1
;
Gang CHEN
1
Author Information
1. Department of Cardiology, Chengdu Fifth People's Hospital, Chengdu, Sichuan 613000, China
- Publication Type:Journal Article
- Keywords:
Unstable angina pectoris;
Heart failure;
Influencing factors
- From:
Journal of Public Health and Preventive Medicine
2025;36(6):184-187
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the current status and influencing factors of heart failure occurrence in patients with unstable angina pectoris (UAP), and to provide a scientific basis for developing individualized prevention and treatment strategies. Methods A total of 310 patients with UAP admitted to the Fifth People's Hospital from October 2021 to October 2024 were selected as study subjects. The current status of the patients' heart failure was statistically analyzed, and the patients were divided into heart failure group and non-heart failure group according to whether they had heart failure. Univariate and logistic multivariate regression analyses were used to analyze the risk factors for the occurrence of heart failure in patients with UAP. Results Among the 310 patients with UAP, 63 cases had heart failure, with an incidence rate of 20.32%. After logistic multivariate analysis, it was found that diabetes mellitus, hyperlipidemia, number of coronary artery lesions, homocysteine and plasma brain natriuretic peptide levels were risk factors of heart failure in patients with UAP, and hemoglobin level was a protective factor (OR: 2.010, 95%CI: 1.063-3.800; OR: 4.495, 95%CI: 2.228-9.067; OR: 2.408, 95%CI: 1.256-4.617; OR: 3.655, 95%CI: 1.812-7.372; OR: 4.693, 95%CI: 2.622-8.399; OR: 0.359, 95%CI: 0.205-0.628, P<0.05). Conclusion The coronary heart disease risk of heart failure is high in patients with UAP, and is affected by comorbidities, number of coronary artery lesions, homocysteine, and plasma brain natriuretic peptide levels. It is necessary to perform clinical screening and pay attention to such patients, and take active prevention and control interventions.
